ADAGE CAPITAL PARTNERS GP LLC 13D and 13G filings for Protagonist Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-07 07:41 am Sale |
2023-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX |
ADAGE CAPITAL PARTNERS GP LLC | 1,291,701 2.240% |
-1,663,299 (-56.29%) |
Filing |
| 2023-04-13 4:30 pm Purchase |
2023-04-03 | 13G | Protagonist Therapeutics, Inc. PTGX |
ADAGE CAPITAL PARTNERS GP LLC | 2,955,000 5.440% |
1,804,955 (+156.95%) |
Filing |
| 2021-02-11 08:05 am Sale |
2020-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX |
ADAGE CAPITAL PARTNERS GP LLC | 1,150,045 2.690% |
-1,049,955 (-47.73%) |
Filing |
| 2020-05-22 4:30 pm Purchase |
2020-05-13 | 13G | Protagonist Therapeutics, Inc. PTGX |
ADAGE CAPITAL PARTNERS GP LLC | 2,200,000 6.390% |
2,200,000 (New Position) |
Filing |